Magnetic Resonance Imaging trials for Stage IV Pancreatic Cancer AJCC v8
All Magnetic Resonance Imaging trials · All Stage IV Pancreatic Cancer AJCC v8 trials
9
Recruiting trials
Phase breakdown
Early Phase 1 1Phase 1 3Phase 2 5Phase 3 1
Recruiting trials studying Magnetic Resonance Imaging for Stage IV Pancreatic Cancer AJCC v8
- A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
- Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
- Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Common questions
How many trials study Magnetic Resonance Imaging for Stage IV Pancreatic Cancer AJCC v8?
9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.